10000|1045|Public
5|$|Aspirin causes an {{increased}} risk of cerebral microbleeds having the appearance on MRI scans of 5 to 10mm or smaller, hypointense (dark holes) patches. Such cerebral microbleeds are important, since they often occur prior to <b>ischemic</b> <b>stroke</b> or intracerebral hemorrhage, Binswanger disease, and Alzheimer's disease.|$|E
5|$|Tirilazad is an {{antioxidant}} steroid derivative that inhibits the {{lipid peroxidation}} that {{is believed to}} {{play a key role}} in neuronal death in stroke and head injury. It demonstrated activity in animal models of stroke, but human trials demonstrated no effect on mortality or other outcomes in subarachnoid haemorrhage and worsened results in <b>ischemic</b> <b>stroke.</b>|$|E
5|$|A {{study of}} a group with a mean dosage of aspirin of 270mg per day {{estimated}} an average absolute risk increase in intracerebral hemorrhage (ICH) of 12 events per 10,000 persons. In comparison, the estimated absolute risk reduction in myocardial infarction was 137 events per 10,000 persons, and a reduction of 39 events per 10,000 persons in <b>ischemic</b> <b>stroke.</b> In cases where ICH already has occurred, aspirin use results in higher mortality, with a dose of about 250mg per day resulting in a relative risk of death within {{three months after the}} ICH around 2.5 (95% confidence interval 1.3 to 4.6).|$|E
40|$|AbstractPurposeThe {{purpose was}} to {{evaluate}} if patients with partial and full fetal-type posterior cerebral artery (PCA) could be more prone to lead to <b>ischemic</b> <b>strokes</b> on multislice computed tomographic angiography (MSCTA). MethodsA total of 202 patients who had undergone MSCTA examinations were divided into three groups: patients with full fetal-type posterior (FTP), patients with partial FTP, and patients without FTP. The odds ratio of having <b>ischemic</b> <b>strokes</b> was calculated. ResultsThe odds of having <b>ischemic</b> <b>strokes</b> in patients with full and partial FTP were 1. 448 and 3. 027, while P values were. 391 and. 0307, respectively. ConclusionPatients with a partial fetal-type PCA could be more prone to develop <b>ischemic</b> <b>strokes...</b>|$|R
50|$|Stroke is {{different}} in children and newborns {{than it is in}} adults. Children have hemorrhagic strokes as often as they have <b>ischemic</b> <b>strokes,</b> while adults {{are more likely to have}} <b>ischemic</b> <b>strokes.</b> Sixty percent of pediatric strokes occur in boys. Causes of stroke are also different in children than they are in adults.|$|R
50|$|Larry N. Vanderhoef, 74, American biochemist, Chancellor of UC Davis (1994-2009), {{complications}} from <b>ischemic</b> <b>strokes.</b>|$|R
5|$|Icos {{developed}} several drugs {{whose purpose}} was to disrupt the process of inflammation in the body. The research program focused on {{the underlying causes of}} inflammation rather than specific disorders. The compounds developed by Icos were tested in clinical trials in the areas of sepsis, multiple sclerosis, <b>ischemic</b> <b>stroke,</b> heart attack, pancreatitis, pulmonary arterial hypertension, chronic obstructive pulmonary disease, interstitial cystitis, psoriasis, hemorrhagic shock, sexual dysfunction, benign prostatic hyperplasia, rheumatoid arthritis, emphysema, chronic bronchitis, and acute respiratory distress syndrome.|$|E
5|$|Low-dose aspirin use irreversibly {{blocks the}} {{formation}} of thromboxane A2 in platelets, producing an inhibitory effect on platelet aggregation during the lifetime of the affected platelet (8–9 days). This antithrombotic property makes aspirin useful for reducing the incidence of heart attacks in {{people who have had}} a heart attack, unstable angina, <b>ischemic</b> <b>stroke</b> or transient ischemic attack. 40mg of aspirin a day is able to inhibit a large proportion of maximum thromboxane A2 release provoked acutely, with the prostaglandin I2 synthesis being little affected; however, higher doses of aspirin are required to attain further inhibition.|$|E
5|$|DST has mixed {{effects on}} health. In {{societies}} with fixed work schedules it provides more afternoon sunlight for outdoor exercise. It alters sunlight exposure; {{whether this is}} beneficial depends on one's location and daily schedule, as sunlight triggers vitamin D synthesis in the skin, but overexposure can lead to skin cancer. DST may help in depression by causing individuals to rise earlier, but some argue the reverse. The Retinitis Pigmentosa Foundation Fighting Blindness, chaired by blind sports magnate Gordon Gund, successfully lobbied in 1985 and 2005 for U.S. DST extensions. DST shifts are associated with higher rates of <b>ischemic</b> <b>stroke</b> {{in the first two}} days after the shift, though not in the week thereafter.|$|E
2500|$|Stroke {{without an}} obvious {{explanation}} is termed [...] "cryptogenic" [...] (of unknown origin); this constitutes 30-40% of all <b>ischemic</b> <b>strokes.</b>|$|R
2500|$|Strokes can be {{classified}} into two major categories: ischemic and hemorrhagic. <b>Ischemic</b> <b>strokes</b> are caused by interruption of the blood supply to the brain, while hemorrhagic strokes result from the rupture of a blood vessel or an abnormal vascular structure. About 87% of <b>strokes</b> are <b>ischemic,</b> the rest being hemorrhagic. Bleeding can develop inside areas of ischemia, a condition known as [...] "hemorrhagic transformation." [...] It is unknown how many hemorrhagic strokes actually start as <b>ischemic</b> <b>strokes.</b>|$|R
40|$|Moyamoya {{disease is}} an {{idiopathic}} vasculopathy, affecting vessels of Circle of Willis. 1 It usually manifests as stroke, {{but can also}} cause seizures and cognitive impairment. 2 <b>Ischemic</b> <b>strokes</b> are common in children and hemorrhagic strokes in adults. 1 We describe our experience with moyamoya disease in four patients who presented with <b>ischemic</b> <b>strokes,</b> at an academic tertiary care center and emphasize that this diagnosis {{should be considered in}} young patients, especially children, who present with stroke...|$|R
25|$|In primary {{prevention}} however, antiplatelet drugs did not {{reduce the risk}} of <b>ischemic</b> <b>stroke</b> but increased the risk of major bleeding. Further studies are needed to investigate a possible protective effect of aspirin against <b>ischemic</b> <b>stroke</b> in women.|$|E
25|$|Intake of artificially {{sweetened}} {{soft drinks}} {{were associated with}} an increased risk of <b>ischemic</b> <b>stroke,</b> all-cause dementia, and Alzheimer’s disease dementia. When comparing daily cumulative intake to 0 per week (reference), the hazard ratios were 2.96 (95% confidence interval, 1.26–6.97) for <b>ischemic</b> <b>stroke</b> and 2.89 (95% confidence interval, 1.18–7.07) for Alzheimer’s disease.|$|E
25|$|Citicoline is {{approved}} for treatment {{in cases of}} head trauma, stroke, and neurodegenerative disease in Japan and Europe. Citicoline improves the clinical outcome following an <b>ischemic</b> <b>stroke,</b> {{as evidenced by the}} reduction in size of lesions caused by ischemic strokes after supplementation. It has been claimed that citicoline reduces rates of death and disability following an <b>ischemic</b> <b>stroke.</b>|$|E
5000|$|Strokes can be {{classified}} into two major categories: ischemic and hemorrhagic. <b>Ischemic</b> <b>strokes</b> are caused by interruption of the blood supply to the brain, while hemorrhagic strokes result from the rupture of a blood vessel or an abnormal vascular structure. About 87% of <b>strokes</b> are <b>ischemic,</b> the rest being hemorrhagic. Bleeding can develop inside areas of ischemia, a condition known as [...] "hemorrhagic transformation." [...] It is unknown how many hemorrhagic strokes actually start as <b>ischemic</b> <b>strokes.</b>|$|R
50|$|Vanderhoef died on October 15, 2015 from {{complications}} due to {{a series}} of <b>ischemic</b> <b>strokes,</b> the first of which occurred in November 2012.|$|R
50|$|<b>Ischemic</b> <b>strokes</b> are {{the most}} {{frequent}} presentation of CADASIL, with approximately 85% of symptomatic individuals developing transient <b>ischemic</b> attacks or <b>stroke(s).</b> The mean age of onset of ischemic episodes is approximately 46 years (range 30-70). A classic lacunar syndrome occurs in at least two-thirds of affected patients while hemispheric strokes are much less common. It is worthy of note that <b>ischemic</b> <b>strokes</b> typically occur {{in the absence of}} traditional cardiovascular risk factors. Recurrent silent strokes, with or without clinical strokes, often lead to cognitive decline and overt subcortical dementia. A case of CADASIL presenting as schizophreniform organic psychosis has been reported.|$|R
25|$|The glymphatic {{system may}} also be {{impaired}} after acute brain injuries such as <b>ischemic</b> <b>stroke,</b> intracranial hemorrhage or subarachnoid hemorrhage. In 2014, a group of researchers from the French Institute of Health and Medical Research (INSERM) demonstrated by MRI that the glymphatic system was impaired after subarachnoid hemorrhage, {{because of the presence}} of coagulated blood in the paravascular spaces. Interestingly, injection of tissue plasminogen activator (a fibrinolytic drug) in the CSF improved glymphatic functioning. In a parallel study, they also demonstrated that the glymphatic system was impaired after <b>ischemic</b> <b>stroke</b> in the ischemic hemisphere, although the pathophysiological basis of this phenomenon remains unclear. Notably, recanalization of the occluded artery also reestablished the glymphatic flow.|$|E
25|$|Complications of {{pre-eclampsia}} {{can affect}} both {{the mother and}} the fetus. Acutely, pre-eclampsia can be complicated by eclampsia, the development of HELLP syndrome, hemorrhagic or <b>ischemic</b> <b>stroke,</b> liver damage and dysfunction, acute kidney injury, and acute respiratory distress syndrome (ARDS).|$|E
25|$|A {{recent study}} (2007) found that {{patients}} taking 200mg of minocycline {{for five days}} within 24 hours of an <b>ischemic</b> <b>stroke</b> showed an improvement in functional state and stroke severity {{over a period of}} three months compared with patients receiving placebo.|$|E
50|$|Cocaine misuse doubles {{both the}} risks of hemorrhagic and <b>ischemic</b> <b>strokes,</b> as well as {{increases}} the risk of other infarctions, such as myocardial infarction.|$|R
40|$|Context Migraine {{is a kind}} {{of primary}} {{headache}} that affects 10 % to 20 % of people worldwide. Recent studies have shown that migraines can be involved in <b>strokes</b> incidences, especially <b>ischemic</b> <b>strokes.</b> Hence, the current study aimed to review evidence in relation to migraine and risk of stroke. Evidence Acquisition A literature search was done for related articles dated between 1993 and 2013 on PubMed, Science Direct, Embase, Web of Science and Scopus for both English and non-English language articles by entering “migraine”, “migraine with aura”, “headache” and “ischemic and hemorrhagic stroke” as keywords. Results In most evaluated studies, there was a positive association between migraine with aura (MA) and <b>strokes</b> incidences, especially <b>ischemic</b> <b>strokes.</b> Moreover, patients with high frequency of migraine attacks had greater odds of having a stroke compared with those who had low frequency of migraine attacks. Also, the association between migraine and stroke was more significant in subjects under 45 years old. Some migraine symptoms such as vomiting and nausea had a protective {{role in the development of}} <b>ischemic</b> <b>strokes.</b> Conclusions Migraine, especially MA, is a risk factor for incidences of <b>strokes,</b> especially <b>ischemic</b> <b>strokes.</b> However, due to conflicting results on the association between different types of migraine and stroke, more studies are needed in this field...|$|R
5000|$|... 2015 - In March {{the company}} {{announced}} it would co-commercialise Athersys's stem cell therapy for <b>ischemic</b> <b>strokes</b> in Japan. The deal could yield upwards of US$205 million.|$|R
25|$|Cerebral venous sinus {{thrombosis}} {{leads to}} stroke due to locally increased venous pressure, which exceeds the pressure {{generated by the}} arteries. Infarcts {{are more likely to}} undergo hemorrhagic transformation (leaking of blood into the damaged area) than other types of <b>ischemic</b> <b>stroke.</b>|$|E
25|$|In 2013 {{approximately}} 6.9 {{million people}} had an <b>ischemic</b> <b>stroke</b> and 3.4 million {{people had a}} hemorrhagic stroke. In 2015 there were about 42.4million people who had previously had a stroke and were still alive. Between 1990 and 2010 the number of strokes which occurred each year decreased by approximately 10% {{in the developed world}} and increased by 10% in the developing world. In 2015, stroke was the second most frequent cause of death after coronary artery disease, accounting for 6.3million deaths (11% of the total). About 3.0 million deaths resulted from <b>ischemic</b> <b>stroke</b> while 3.3 million deaths resulted from hemorrhagic stroke. About half of people who have had a stroke live less than one year. Overall, two thirds of strokes occurred in those over 65 years old.|$|E
25|$|There are {{two types}} of strokes: <b>ischemic</b> <b>stroke</b> and hemorrhagic stroke. An <b>ischemic</b> <b>stroke</b> happens when a person’s artery, which {{supplies}} blood to different areas of the brain, becomes blocked with a blood clot. This type of stroke happens 80% of the time. The blood clot may form in the blood vessel, which is called a thrombus, or the blood clot can travel from somewhere else in the blood system that is called an embolus. A hemorrhagic stroke occurs when a blood vessel in the brain ruptures or bursts. Overall, people experience bleeding inside or around brain tissue. This type of stroke happens 20% of the time and is very serious. The most common causes of hemorrhagic stroke are weak vessels, traumatic injury, chronic high blood pressure hypertension, and an aneurysm.|$|E
40|$|One of the {{neurologic}} {{complications of}} {{human immunodeficiency virus}} infection are cerebrovascular accidents. In HIV infected patients, <b>ischemic</b> <b>strokes</b> have been reported secondary to nonbacterial thrombotic endocarditis and cerebral arteritis. We describe an unusual cause of stroke in HIV- 1 infection: Herpes Zoster ophtalmicus with contralateral hemiplegia. One of the neurologic complications of human immunodeficiency virus infection are cerebrovascular accidents. In HIV infected patients, <b>ischemic</b> <b>strokes</b> have been reported secondary to nonbacterial thrombotic endocarditis and cerebral arteritis. We describe an unusual cause of stroke in HIV- 1 infection: Herpes Zoster ophtalmicus with contralateral hemiplegia...|$|R
5000|$|... 2007 - Hughes Hubbard led the {{drafting}} of a historic $4.85 billion global settlement program to resolve over 99.9 percent of eligible Vioxx claims against Merck alleging heart attacks, <b>ischemic</b> <b>strokes</b> and sudden cardiac death.|$|R
5000|$|Moyamoya disease (a rare, chronic {{cerebrovascular}} occlusive {{disease of}} unknown cause, characterized by progressive stenosis {{of the arteries}} of the circle of Willis leading to an abnormal capillary network and resultant <b>ischemic</b> <b>strokes</b> or cerebral hemorrhages) ...|$|R
25|$|High {{cholesterol}} levels have been inconsistently associated with (<b>ischemic)</b> <b>stroke.</b> Statins {{have been shown}} {{to reduce the risk of}} stroke by about 15%. Since earlier meta-analyses of other lipid-lowering drugs did not show a decreased risk, statins might exert their effect through mechanisms other than their lipid-lowering effects.|$|E
25|$|Wepfer also {{identified}} the main arteries supplying the brain, the vertebral and carotid arteries, and identified {{the cause of}} a type of <b>ischemic</b> <b>stroke</b> known as a cerebral infarction when he suggested that apoplexy might be caused by a blockage to those vessels. Rudolf Virchow first described the mechanism of thromboembolism as a major factor.|$|E
25|$|Higher {{levels of}} vWF {{are more common}} among people that have had <b>ischemic</b> <b>stroke</b> (from blood-clotting) for the first time. Occurrence is not {{affected}} by ADAMTS13, and the only significant genetic factor is the person's blood group.High plasma vWF levels {{were found to be}} an independent predictor of major bleeding in anticoagulated atrial fibrillation patients.|$|E
40|$|License, which permits {{unrestricted}} use, distribution, {{and reproduction}} in any medium, provided the original work is properly cited. Background. <b>Ischemic</b> and hemorrhagic <b>strokes</b> have different pathophysiologies and possibly different long-term cerebral and functional implications. Hemorrhagic strokes expose {{the brain to}} irritating effects of blood and <b>ischemic</b> <b>strokes</b> reflect localized or diffuse cerebral vascular pathology. Methods. Participants were individuals who suffered either an ischemic...|$|R
40|$|BackgroundEpidemiological {{studies are}} needed to {{evaluate}} the impact of the recent changes in clinical practice on the incidence of cardioembolic stroke with atrial fibrillation (CE/AF <b>stroke).</b> MethodsOverall <b>ischemic</b> <b>strokes</b> were prospectively ascertained in the population-based registry of Dijon, France (150, 000 inhabitants), from 1985 to 2006. We evaluated trends in incidence rates, risk factors, prestroke therapy, and survival in CE/AF <b>stroke.</b> Results 3064 <b>ischemic</b> <b>strokes</b> including 572 (18. 7 %) CE/AF strokes were recorded. Over the 22 years, a decrease in the incidence of overall CE/AF stroke was noted ([IRR] 0. 9858, 95 % CI 0. 9731 - 0. 9986; p= 0. 03). We observed a higher prevalence of previous AF, previous myocardial infarction, and patients aged > 70 years in CE/AF strokes (p< 0. 0001) whereas hypercholesterolemia was more prevalent in other <b>ischemic</b> <b>strokes</b> (p= 0. 003). A significant increase in the use of anticoagulants and antiplatelet agents was noted, and was particularly pronounced for CE/AF strokes with previous AF. For CE/AF strokes, survival rates were 72 % at 1 month (95 % CI 0. 68 - 0. 76), 52 % at 1 year (95 % CI 0. 48 - 0. 56), and 43 % (95 % CI 0. 39 - 0. 48) at 2 years, and remained lower than those of other <b>ischemic</b> <b>strokes.</b> ConclusionsThe decrease in the incidence of CE/AF stroke may reflect the increase in the utilization of antithrombotic therapy in patients with AF, but the use of such therapies will have to increase further because of the expected ageing of the population in coming years...|$|R
50|$|It is {{estimated}} that lacunar infarcts account for 25% of all <b>ischemic</b> <b>strokes,</b> with an annual incidence of approximately 15 per 100,000 people. They may be more frequent in men and in people of African, Mexican, and Hong Kong Chinese descent.|$|R
